| Schedule of Financial Information by Segment |
The following tables present financial information by segment:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Nine months ended | | (in millions) | September 26, 2026 | | September 27, 2025 | | September 26, 2026 | | September 27, 2025 | | Net sales to external customers: | | | | | | | | | Front Line Care | $ | 1,706 | | | $ | 1,634 | | | $ | 4,976 | | | $ | 4,752 | | | Surgical Solutions | 1,659 | | | 1,538 | | | 4,853 | | | 4,494 | | | Laboratory and Diagnostics | 272 | | | 239 | | | 813 | | | 751 | | | Medline Brand | 3,637 | | | 3,411 | | | 10,642 | | | 9,997 | | | Supply Chain Solutions | 4,219 | | | 3,704 | | | 12,251 | | | 10,648 | | | Consolidated net sales to external customers | $ | 7,856 | | | $ | 7,115 | | | $ | 22,893 | | | $ | 20,645 | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Segment Adjusted EBITDA: | | | | | | | | | Medline Brand | $ | 943 | | | $ | 821 | | | $ | 2,775 | | | $ | 2,541 | | | Supply Chain Solutions | 184 | | | 205 | | | 575 | | | 588 | | | Total segment adjusted EBITDA | 1,127 | | | 1,026 | | | 3,350 | | | 3,129 | | | Corporate & Other | (167) | | | (167) | | | (554) | | | (467) | | | Interest expense, net | (118) | | | (213) | | | (373) | | | (646) | | | Depreciation and amortization | (259) | | | (253) | | | (769) | | | (750) | | | Inventory-related adjustments | (122) | | | (2) | | | (154) | | | (38) | | | Stock-based compensation expense | (29) | | | (15) | | | (81) | | | (52) | | | Litigation gains, net | — | | | — | | | — | | | 47 | | Transaction-related costs (1) | (30) | | | (12) | | | (94) | | | (35) | | | | | | | | | | | | | | | | | | | | | | | | | | Other non-core charges, net (2) | (16) | | | (19) | | | (413) | | | (146) | | | Income before income taxes | $ | 386 | | | $ | 345 | | | $ | 912 | | | $ | 1,042 | |
(1) Represents acquisition and integration-related costs and IPO and subsequent offerings related costs. (2)Represents costs related to specified transformation and implementation projects, loss on debt extinguishment and other debt refinancing costs and fees related to specified financing transactions, and other items. The impact of a fire at the distribution center in Tracy, costs attributable to specified remediation activities undertaken in response to FDA observations and warning letters, and recall and discontinuation costs related to Medline Brand beds are included in the 2026 periods. Foreign exchange losses directly attributable to the remeasurement of euro-denominated term loans is included in the 2025 periods.
|
| Schedule of Sales and Long-Lived Assets by Geographical Areas |
The following tables present information by sales office and geographic area:
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Three months ended | | Nine months ended | | (in millions) | September 26, 2026 | | September 27, 2025 | | September 26, 2026 | | September 27, 2025 | | | | | | Net sales to external customers: | | | | | | | | | | | | Acute care (1) | $ | 5,471 | | | $ | 4,880 | | | $ | 16,003 | | | $ | 14,168 | | | | | | Non-Acute care (2) | 1,867 | | | 1,756 | | | 5,344 | | | 5,061 | | | | | | | United States | 7,338 | | | 6,636 | | | 21,347 | | | 19,229 | | | | | | | International | 518 | | | 479 | | | 1,546 | | | 1,416 | | | | | | | Consolidated net sales to external customers | $ | 7,856 | | | $ | 7,115 | | | $ | 22,893 | | | $ | 20,645 | | | | | |
(1) Acute care represents hospital health systems. (2) Non-Acute care represents other sites of care including outpatient, post acute, physician’s office, surgery centers, and all other. | | | | | | | | | | | | | (in millions) | September 26, 2026 | | December 31, 2025 | Long-lived assets by geographical area (1): | | | | | United States | $ | 4,364 | | | $ | 4,433 | | | International | 838 | | | 777 | | | Consolidated long-lived assets, net | $ | 5,202 | | | $ | 5,210 | |
(1) Includes property, plant, and equipment, net, and operating lease right-of-use assets.
|